Related Experiment Video

Updated: May 8, 2026

Isolation and Characterization of Dendritic Cells and Macrophages from the Mouse Intestine
09:25

Isolation and Characterization of Dendritic Cells and Macrophages from the Mouse Intestine

Published on: May 21, 2012

Dendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signaling

Janne K Nieminen1, Mirja Niemi, Taina Sipponen

  • 1Immune Response Unit, Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland. janne.nieminen@thl.fi

Plos One
|August 17, 2013
PubMed

Insights

Dendritic cell (DC) signaling is altered in Crohn's disease (CD). Impaired STAT signaling in DCs, particularly reduced IL-6 responsiveness in plasmacytoid DCs, may drive immune dysregulation in CD patients.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Signaling

Background:

  • Dendritic cells (DCs) and STAT proteins are implicated in Crohn's disease (CD).
  • JAK/STAT signaling pathways in DCs are not well understood in CD.
  • Existing research highlights potential roles for DC abnormalities and STAT protein dysregulation in CD pathogenesis.

Purpose of the Study:

  • To investigate STAT1 and STAT3 signaling pathways in DC subsets from CD patients.
  • To evaluate circulating DC counts and activation markers in CD.
  • To elucidate the functional consequences of altered IL-6 signaling on pDCs in CD.

Main Methods:

  • Flowcytometric single-cell-based phosphoepitope assay to assess STAT1 and STAT3 phosphorylation in DC subsets.
  • Quantification of circulating DC subsets (pDCs, mDCs) and their immunophenotype.
  • Measurement of plasma IL-6 levels and correlation with disease activity and STAT phosphorylation.

Main Results:

  • Impaired IL-6 and IFN-α-induced STAT3 phosphorylation in plasmacytoid DCs (pDCs) and impaired IFN-α-induced STAT1 and STAT3 phosphorylation in myeloid DCs (mDCs) from CD patients.
  • Intact IFN-γ-induced STAT1 signaling in both DC subtypes.
  • Elevated plasma IL-6 levels correlated with CD disease activity; decreased pDC and specific mDC counts, with increased CD40 on other mDCs, were observed in CD.
  • IL-6 treatment of healthy pDCs altered T-cell priming towards Th2 and increased IL-10 expression in T cells.

Conclusions:

  • DC signaling pathways, particularly STAT signaling, are dysregulated in Crohn's disease.
  • Reduced IL-6 responsiveness in pDCs and attenuated IFN-α signaling in both DC subtypes may contribute to immunological dysregulation in CD.
  • These findings highlight DCs as potential therapeutic targets in managing immune responses in CD.

More Related Videos

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...